Effect of numbers of metabolic syndrome components on mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis with metabolic syndrome

被引:2
|
作者
Park, P. G. [1 ]
Pyo, J. Y. [1 ]
Ahn, S. S. [1 ]
Song, J. J. [1 ,2 ]
Park, Y-B [1 ,2 ]
Huh, J. H. [3 ]
Lee, S-W [1 ,2 ]
机构
[1] Yonsei Univ, Dept Internal Med, Div Rheumatol, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Inst Immunol & Immunol Dis, Coll Med, Seoul, South Korea
[3] Hallym Univ, Dept Internal Med, Div Endocrinol & Metab, Sacred Heart Hosp, Anyang, South Korea
关键词
antineutrophil cytoplasmic antibody; vasculitis; metabolic syndrome; components; all-cause mortality; CARDIOVASCULAR RISK; SCORE; DISEASE; ADULTS; INDEX; KOREA;
D O I
10.55563/clinexprheumatol/k4m3it
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective This study investigated the effect of the number of metabolic syndrome (MetS) components on all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV) with MetS. Methods The medical records of 93 AAV patients with MetS were retrospectively reviewed. MetS was diagnosed when three or more the following MetS components for Asians were met: (i) increased waist circumference; ii) high blood pressure; (iii) hypertriglyceridaemia; (iv) low level of high-density lipoprotein (HDL)-cholesterol; and (v) impaired fasting glucose (IFG) or type 2 diabetes mellitus (T2DM). All-cause mortality was defined as death owing to any aetiology. Results The median age was 61.4 years and 33 patients were men. Among 93 AAV patients with MetS, as the number of MetS components increased, the cumulative patient survival rate significantly decreased (p = 0.024). Compared to surviving AAV patients with MetS, deceased AAV patients with MetS were older, had higher Birmingham vasculitis activity score (BVAS) and Five-factor score (FFS), a lower frequency of IFG or T2DM, and a higher number of MetS components. In the multivariable Cox analysis, AAV patients with MetS who had all five MetS components were approximately 62 times more susceptible to all-cause mortality than those who had only three components. In terms of IFG or T2DM, patients with only IFG exhibited a significantly lower cumulative patients??? survival rate than those without. Conclusion The presence of many MetS components at the initial diagnosis of AAV was an independent and significant predictor of all-cause mortality in AAV patients with MetS.
引用
收藏
页码:758 / 764
页数:7
相关论文
共 50 条
  • [31] Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis
    McGregor, JulieAnne G.
    Hogan, Susan L.
    Kotzen, Elizabeth S.
    Poulton, Caroline J.
    Hu, Yichun
    Negrete-Lopez, Roberto
    Kidd, Jason M.
    Katsanos, Suzanne L.
    Bunch, Donna O.
    Nachman, Patrick H.
    Falk, Ronald J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 : i123 - i131
  • [32] The Expanding Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Armamentarium
    Mcgovern, Dominic P.
    Jones, Rachel B.
    Jayne, David R. W.
    Smith, Rona M.
    DRUGS, 2025, 85 (03) : 325 - 341
  • [33] Current Landscape of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Lally, Lindsay
    Spiera, Robert
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2015, 41 (01) : 1 - +
  • [34] Renal Involvement in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Zonozi, Reza
    Niles, John L.
    Cortazar, Frank B.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2018, 44 (04) : 525 - +
  • [35] The role of complement in antineutrophil cytoplasmic antibody-associated vasculitis
    Trejo, Maria A. C. Wester
    Trouw, Leendert A.
    Bajema, Ingeborg M.
    CURRENT OPINION IN RHEUMATOLOGY, 2019, 31 (01) : 3 - 8
  • [36] Relapse Prediction in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Riogh, Eithne Nic an
    Little, Mark A.
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 (10) : 1473 - 1474
  • [37] Cutaneous Manifestations of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Micheletti, Robert G.
    Fuxench, Zelma Chiesa
    Craven, Anthea
    Watts, Richard A.
    Luqmani, Raashid A.
    Merkel, Peter A.
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 (10) : 1741 - 1747
  • [38] Severe Infection in Antineutrophil Cytoplasmic Antibody-associated Vasculitis
    Mohammad, Aladdin J.
    Segelmark, Marten
    Smith, Rona
    Englund, Martin
    Nilsson, Jan-Ake
    Westman, Kerstin
    Merkel, Peter A.
    Jayne, David R. W.
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (10) : 1468 - 1475
  • [39] SURVIVAL ANALYSIS IN ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS
    Petelytska, L.
    Iaremenko, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 571 - 572
  • [40] Pantoprazole and perinuclear antineutrophil cytoplasmic antibody-associated vasculitis
    Jacobs-Kosmin, D
    Derk, CT
    Sandorfi, N
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (03) : 629 - 632